Scholar Rock prices upsized $85M offering (NASDAQ:SRRK)
Phase 3 clinical-stage biopharmaceutical company Scholar Rock (NASDAQ:SRRK) priced an upsized underwritten public offering of 12.41M shares at a public ...
Phase 3 clinical-stage biopharmaceutical company Scholar Rock (NASDAQ:SRRK) priced an upsized underwritten public offering of 12.41M shares at a public ...
Mikko Lemola Hives treatment developer Third Harmonic Bio (THRD) has priced its upsized $185M initial public offering. The biotech company ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.